Compound Detail
CHEMBL4535706
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4535706 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | JOJPMWILWKDCNM-UHFFFAOYSA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
8
Publications
0
Known Names
Molecular Properties
347.4
MW (Da)
4.12
ALogP
4
HBA
1
HBD
59.0
PSA (Ų)
0.77
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 4.97
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 10820.0 | nM | 4.97 | Antiproliferative activity against human HepG2 cells assessed as reduction in ce... | 31228810 |
| HeLa | IC50 | = | 16440.0 | nM | 4.78 | Antiproliferative activity against human HeLa cells assessed as reduction in cel... | 31228810 |
| MCF7 | IC50 | = | 17300.0 | nM | 4.76 | Antiproliferative activity against human MCF7 cells assessed as reduction in cel... | 31228810 |
| HCT-116 | IC50 | = | 26110.0 | nM | 4.58 | Antiproliferative activity against human HCT116 cells assessed as reduction in c... | 31228810 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31228810 | 10.1016/j.ejmech.2019.06.021 | PI3-kinase p110-delta/p85-alpha | 2 |
| 31228810 | 10.1016/j.ejmech.2019.06.021 | Serine/threonine-protein kinase mTOR | 1 |
| 31228810 | 10.1016/j.ejmech.2019.06.021 | A549 | 1 |
| 31228810 | 10.1016/j.ejmech.2019.06.021 | HeLa | 1 |
| 31228810 | 10.1016/j.ejmech.2019.06.021 | HCT-116 | 1 |
| 31228810 | 10.1016/j.ejmech.2019.06.021 | HepG2 | 1 |
| 31228810 | 10.1016/j.ejmech.2019.06.021 | A-375 | 1 |
| 31228810 | 10.1016/j.ejmech.2019.06.021 | MCF7 | 1 |
Data from ChEMBL 36 via Core Engine